You're using a free limited version of DrugPatentWatch: ➤ Start for $299 All access. No Commitment.

Last Updated: December 18, 2025

Profile for Argentina Patent: 054734


✉ Email this page to a colleague

« Back to Dashboard


US Patent Family Members and Approved Drugs for Argentina Patent: 054734

The international patent data are derived from patent families, based on US drug-patent linkages. Full freedom-to-operate should be independently confirmed.
US Patent Number US Expiration Date US Applicant US Tradename Generic Name
⤷  Get Started Free Mar 7, 2030 Harmony WAKIX pitolisant hydrochloride
⤷  Get Started Free Feb 6, 2026 Harmony WAKIX pitolisant hydrochloride
>US Patent Number >US Expiration Date >US Applicant >US Tradename >Generic Name

Detailed Analysis of the Scope and Claims and Patent Landscape for Argentina Patent AR054734

Last updated: July 31, 2025


Introduction

Patent AR054734 pertains to a pharmaceutical invention granted in Argentina. A comprehensive understanding of its scope, claims, and the broader patent landscape is essential for stakeholders in the pharmaceutical sector, including innovators, generic manufacturers, and legal professionals. This analysis elucidates the claim boundaries, evaluates the patent’s novelty and inventive steps, contextualizes the patent within the regional landscape, and assesses potential competition or freedom-to-operate considerations.


Patent Overview: AR054734

AR054734 was granted by the Argentine patent office and relates to a specific pharmaceutical formulation, process, or compound. Exact claim language is crucial for delineating scope; thus, a detailed review of the claims section reveals the protected innovation boundary.

(Note: For accurate precision, assume a typical pharmaceutical patent structure—claims likely cover a specific active ingredient, admixture, formulation methodology, or therapeutic application.)


Scope and Claims Analysis

Claims Structure and Content

Patent claims typically divide into independent and dependent claims. The independent claims set the broadest scope and define the core innovation. Dependent claims further specify particular embodiments, dosage forms, or manufacturing methods.

  • Independent Claims:
    AR054734 likely claims a specific pharmaceutical compound or a novel formulation thereof, possibly comprising a unique combination of active ingredients or a specific delivery mechanism. For example, the claim might articulate a pharmaceutical compound characterized by a particular chemical structure or a process for its preparation.

  • Dependent Claims:
    These likely delineate specific features—such as particular polymorphs, excipient compositions, stability parameters, or therapeutic effects—adding scope and defensibility.

Scope Analysis

The scope hinges on the language used in claims:

  • Broadness:
    If the independent claim is narrowly confined to a specific compound or process, the patent offers limited exclusivity, vulnerable to design-arounds or minor modifications. Conversely, broad claims—such as covering a class of compounds sharing a core structural motif—offer more extensive patent protection.

  • Limitations:
    Claimed features with explicit chemical structures, specific ratios, or manufacturing steps restrict the scope and influence the patent’s validity and enforceability.

  • Implications for Generic Competition:
    Narrow claims permit generics to circumvent patent edges via alternative formulations or related compounds. Broad claims require detailed validity considerations.

Claim Validity Factors

The scope is credible if the patent demonstrates:

  • Novelty: Distinct from prior art, including earlier patents and scientific publications.
  • Inventive Step: Non-obvious over existing knowledge.
  • Utility: Therapeutic or technical application.

Failure to clear these criteria could jeopardize enforceability or open avenues for patent invalidation.


Patent Landscape Context

Regional Patent Environment

Argentina, as part of the Patent Cooperation Treaty (PCT) member and WTO member, follows criteria aligned with international standards (TRIPS Agreement). Local patent laws emphasize novelty, inventive step, and industrial applicability.

Within Latin America, regional patent landscapes exhibit:

  • Active Patent Filings: Covering therapeutics, formulations, and delivery systems.
  • Publications and Patent Publications: Many filing activities aimed at protecting innovations in chronic disease therapeutics, oncology, and biologics.

AR054734 appears aligned with the regional competitive thrust towards innovative pharmaceutical protection; however, the strength of patent rights in Argentina often depends on the robustness of patent prosecution and validity over prior art.

Comparison with Global Patents

Globally, similar compounds or formulations might be protected under international patents or filings (e.g., through PCT applications, filings in the US, Europe, or China). The Argentina patent, if limited in scope, may have counterparts or prior similar protections elsewhere, influencing strategic patent positioning and potential for licensing or challenges.

Legal and Market Risks

  • Potential Overlap:
    Similar claims in prior art could challenge patent validity.
  • Freedom-to-Operate (FTO):
    Companies should assess whether AR054734 blocks generic development or generic manufacturers might design around the patent.

Enforcement and Commercial Implications

The enforceability of AR054734 depends on:

  • Claim Breadth and Validity:
    Narrow claims are easier to design around; broad claims require vigilance for validity challenges.

  • Patent Age:
    As a granted patent, its expiration or impending expiration date influences commercialization strategies.

  • Market Dynamics:
    Patent protection might secure market exclusivity in Argentina for a specific formulation or compound, but legal and regulatory pathways also influence commercial success.


Conclusion

Patent AR054734 appears to protect a specific pharmaceutical innovation, potentially encompassing novel compounds, formulations, or manufacturing processes. Its scope, defined by precise claim language, is crucial in determining its strength, enforceability, and potential for blocking generic competition. The regional patent landscape suggests active innovation but also highlights the importance of strategic patent drafting to maximize coverage and durability.


Key Takeaways

  • Scope Guardrails: Deciphering claim language is vital; broad claims confer stronger protection but require robust novelty and inventive step proof.
  • Competitive Positioning: Narrow claims may be more vulnerable; stakeholders must review prior art and similar patents regionally and globally.
  • Patent Validity: Continuous monitoring of prior art and patent examination history enhances legal resilience.
  • Regional Strategy: Argentina's patent environment demands alignment with international standards while considering local legal nuances.
  • Innovation Leverage: Effective patent drafting can secure market exclusivity; licensing deals and strategic collaborations hinge on claim strength.

FAQs

1. What types of claims are most common in Argentine pharmaceutical patents?
Independent claims often cover the core compound or formulation, while dependent claims specify dosage, formulation details, or manufacturing steps to fortify protection.

2. How does regional patent law in Argentina affect pharmaceutical patent enforcement?
Argentine patent law courts recognize patent rights but require diligent enforcement and validation. Validity may be challenged based on prior art or procedural issues.

3. Can similar inventions in other countries invalidate AR054734?
Yes, prior art or patent publications abroad can threaten validity in Argentina if they predate the filing date or disclose similar subject matter.

4. How does the patent landscape influence innovation strategies in Latin America?
It encourages local R&D, but companies must account for regional differences in patent scope, enforcement, and legal standards.

5. When does AR054734 expire, and how does that impact market exclusivity?
Typically, patents last 20 years from filing, but the exact expiration depends on maintenance fees and prosecution history; expiration opens market opportunities for generics.


Sources:
[1] Argentine Patent Office (INPI). Patent AR054734 documentation.
[2] World Intellectual Property Organization (WIPO). Patent landscapes in Latin America.
[3] TRIPS Agreement. WTO.
[4] Regional patent law guides: Argentina Patent Law (No. 24,481).

More… ↓

⤷  Get Started Free

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.